|
|
Blood, 1 July 2006, Vol. 108, No. 1, pp. 337-345.
Prepublished online as a Blood First Edition Paper on March 9, 2006; DOI 10.1182/blood-2005-12-4769.
 Previous Article | Next Article 
Submitted December 1, 2005
Accepted February 22, 2006
Gene expression profiles of CD34+ cells in myelodysplastic syndromes: involvement of interferon stimulated genes and correlation to FAB subtype and karyotype
Andrea Pellagatti, Mario Cazzola, Aristoteles A Giagounidis, Luca Malcovati, Matteo G Della Porta, Sally Killick, Lisa J Campbell, Li Wang, Cordelia F Langford, Carrie Fidler, David Oscier, Carlo Aul, James S Wainscoat, and Jacqueline Boultwood*
LRF Molecular Haematology Unit, NDCLS, John Radcliffe Hospital, Oxford, United Kingdom
Division of Hematology, University of Pavia Medical School, IRCCS Policlinico S. Matteo, Pavia, Italy
Medizinische Klinik II, St Johannes Hospital, Duisburg, Germany
Department of Haematology, Royal Bournemouth Hospital, Bournemouth, United Kingdom
The Sanger Institute, Microarray Facility, Cambridge, United Kingdom
* Corresponding author; email: jacqueline.boultwood{at}ndcls.ox.ac.uk.
In order to gain insight into the poorly understood pathophysiology of the myelodysplastic syndromes (MDS), we have determined the gene expression profiles of the CD34+ cells of 55 MDS patients using a comprehensive array platform. These profiles showed many similarities to reported interferon- induced gene expression in normal CD34+ cells; indeed the two most up-regulated genes, IFIT1 and IFITM1, are interferon stimulated genes (ISG). Alterations in the expression of ISG may play a role in the hematological features of MDS, such as peripheral blood cytopenias. Up-regulation of IFIT1 is a potential diagnostic marker for MDS. We determined whether distinct gene expression profiles were associated with specific FAB and cytogenetic groups. CD34+ cells from patients with refractory anemia with ringed sideroblasts (RARS) showed a particular gene expression profile characterized by up-regulation of mitochondrial-related genes, and in particular of those of heme synthesis (e.g. ALAS2). CD34+ cells from patients with the del(5q) had a distinct gene expression profile, characterized by down-regulation of genes assigned to 5q, and up-regulation of the histone HIST1 gene cluster at chromosome 6p21 and of genes related to the actin cytoskeleton. This study provides important and new insights into the pathophysiology of MDS.
 CiteULike  Connotea  Del.icio.us  Digg  Reddit  Technorati What's this?
This article has been cited by other articles:
|
|
|
|
 
A. H. Schmitt-Graeff, S.-S. Teo, M. Olschewski, F. Schaub, S. Haxelmans, A. Kirn, P. Reinecke, U. Germing, and R. C. Skoda
JAK2V617F mutation status identifies subtypes of refractory anemia with ringed sideroblasts associated with marked thrombocytosis
Haematologica,
January 1, 2008;
93(1):
34 - 40.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Mohamedali, J. Gaken, N. A. Twine, W. Ingram, N. Westwood, N. C. Lea, J. Hayden, N. Donaldson, C. Aul, N. Gattermann, et al.
Prevalence and prognostic significance of allelic imbalance by single-nucleotide polymorphism analysis in low-risk myelodysplastic syndromes
Blood,
November 1, 2007;
110(9):
3365 - 3373.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
L. Malcovati, U. Germing, A. Kuendgen, M. G. Della Porta, C. Pascutto, R. Invernizzi, A. Giagounidis, B. Hildebrandt, P. Bernasconi, S. Knipp, et al.
Time-Dependent Prognostic Scoring System for Predicting Survival and Leukemic Evolution in Myelodysplastic Syndromes
J. Clin. Oncol.,
August 10, 2007;
25(23):
3503 - 3510.
[Abstract]
[Full Text]
[PDF]
|
|
|
|
|
|
|
A. Ganser, M. A. Morgan, and E. M. Weissinger
Going from genes to proteins in myelodysplastic syndromes
PNAS,
January 23, 2007;
104(4):
1109 - 1110.
[Full Text]
[PDF]
|
|
|
|
|
|
|
P. Fenaux and C. Kelaidi
Treatment of the 5q- Syndrome
Hematology,
January 1, 2006;
2006(1):
192 - 198.
[Abstract]
[Full Text]
[PDF]
|
|
|
| |
